TLDR: Reveal HealthTech, an AI transformation partner for healthcare and life sciences, has successfully closed a $7.2 million Series A funding round led by Leo Capital, with additional investment from Sanos Capital. The funding will be used to expand its AI-driven solutions, including BioCanvas and Prism AI, and strengthen its market presence in the U.S. and globally.
Reveal HealthTech, a rapidly growing AI transformation partner specializing in the U.S. healthcare and life sciences sectors, has announced the successful completion of its Series A funding round, securing $7.2 million. The investment was spearheaded by Leo Capital, with significant participation from Sanos Capital. This capital injection is set to accelerate the company’s mission to operationalize AI responsibly within healthcare, focusing on clinically relevant, safe, and scalable solutions.
Founded in 2023 and incubated by W Health Ventures and 2070 Health, Reveal HealthTech has quickly established itself as a “healthcare AI specialist.” The company aims to bridge the gap between cutting-edge artificial intelligence and deep healthcare expertise.
Sanchit Mullick, Founder of Reveal HealthTech, emphasized the company’s objective to make AI a trusted and accountable partner in healthcare. He noted that the idea for the company stemmed from the vast amounts of digital data generated over two decades of electronic health record adoption in the United States, which presented a “gold mine of digital data that could be leveraged.” Mullick clarified that their goal is not to replace doctors but to “amplify and streamline clinical workflows,” stating that “AI in healthcare is often equated with clinical decision support. But that’s just a sliver of the opportunity.”
The fresh capital will be strategically deployed to expand Reveal HealthTech’s product capabilities, strengthen its sales channels, and deepen partnerships across the healthcare and life sciences industries. The company’s flagship offerings include:
BioCanvas®: A multimodal AI platform designed to accelerate use cases such as clinical trial recruitment and oncology research.
Prism AI®: A framework enabling the rapid creation of intelligent agents for workflow automation in healthcare operations.
Reveal HealthTech has already demonstrated tangible impact. In one notable deployment, the company supported a $40 billion U.S. medical device manufacturer in improving patient adherence by 10 to 15 percent through AI-powered data integration, leading to better outcomes in chronic disease management. This project also created reusable blueprints for future clients.
Rajul Garg, Partner at Leo Capital, highlighted Reveal’s ability to craft tailored, time-bound AI solutions that deliver both clinical and business impact. Dr. Pankaj Jethwani, Managing Partner at W Health Ventures, also commented on the company’s potential.
The company currently employs approximately 120 people across the U.S. and India, with leadership based in the U.S. and a large-scale development team in Bengaluru.
As part of its growth strategy, Reveal HealthTech has also announced its entry into the Cipher Collective, a collaborative network of AI-driven health technology providers focused on transforming care delivery worldwide.
Also Read:
- Predoc Secures $30 Million to Revolutionize Healthcare Data Management with AI-Powered Automation
- CHARM Therapeutics Secures $80 Million Series B to Advance AI-Powered Oncology Drug for AML into Clinic
This funding milestone positions Reveal HealthTech to play a pivotal role in accelerating AI adoption and unlocking new efficiencies across the global healthcare ecosystem.
